Animal gene-editing researchers leaving US to escape FDA’s ‘regulatory confusion’

cows
Gene-edited animals face uncertain future under proposed FDA regulations

In a few weeks, reproductive biologist Charles Long will travel from Texas to São Paulo, Brazil in search of collaborators willing to take on his studies of gene-edited cattle. He is reluctant to ship the project away from his laboratory at Texas A&M University in College Station. But after 20 years of struggling to win US government funding for his research, Long says that he is done.

“We’ve essentially given up,” he says. “I’m going to move the entire damn project down there.”

US researchers who develop genetically engineered livestock have long dealt with….an uncertain path to market. Many had hoped that the advent of genome-editing technologies….would mean less oversight by the….FDA….

But in 2017, the FDA released draft guidance that suggested it will regulate gene-edited animals, too, as ‘animal drugs’. The only animal that the FDA has approved via that pathway is a fast-growing genetically engineered salmon, in a decision that was decades in the making….

…

That leaves US researchers in a bind. Federal funding for genetically engineered or edited livestock is in short supply. Geneticist Kevin Wells of the University of Missouri in Columbia can recall only one such grant in the last 30 years. Researchers have leaned on industry funding to pick up the slack — but this, too, might run dry if companies can’t bring their animals to market.

Read full, original article: Gene-edited animal creators look beyond US market

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Cancer mRNA Vaccine Concept
'A new frontier': Though scorned by RFK Jr., personalized mRNA vaccine offers hope for many suffering from melanoma skin cancer
Screenshot-2026-10-22-at-12.45.14-PM
Pennsylvania tells doctors to prepare for a surge in newborn measles cases—a complication unseen in decades
Healthy Food Sensitivity Test Collection
Viewpoint: That’ll be $300: The wellness industry’s junk science scam to ‘fix’ your immune system that isn’t broken
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
West-Virginia-SNAP-Water-Bottle-Sticker
A ‘shining success’ or 'empty promises’: Two years along, West Virginians assess MAHA’s food promises
Crimson Drips Over the White House
In Trump administration redirect, U.S. steers NIH sharply away from biodefense and pandemic preparedness
Screenshot 2026-10-23 at 2.28
Climate disruption alert: Global emissions hold steady while Trump’s America fuels more warming
Diet Soda with Measuring Tape 2
Science challenges anti-soda activists: No, sodas won’t make you fat
Rustic Skillet of Raw Brains
‘Weird food’? Testicle- and brain-eating, supplement-gulping MAHA health food enthusiasts defend their ‘natural’ diets
Screenshot 2026-10-16 at 5.38
PFAS in Agriculture: Science, Uncertainty, and Risk Communication
Screenshot-2026-10-19-at-12.04.51-PM
Victims of their own success: As memories of killer diseases fade, vaccine rejectionism soars
Strawberry Clamshell with Warning Sticker
Viewpoint: Activists hype ‘dangerous level’ of pesticide residues in Driscoll berries: Separating health concerns from fear-mongering
Vibrant Social Media Confetti Explosion
Health misinformation minefield: Countering online deluge by copying its style
Prescription Capsules Scattered on Twenty-Dollar Bills
Facts & Fallacies podcast: America's health care system is broken. A doctor explains how to fix it, Part 2
Author-Presenting-Good-Energy
'Disillusioned': Controversial RFK Jr. ally and MAHA leader Calley Means quits Trump advisory role
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.